https://www.angelinipharma.at/2026-01-20weekly1https://www.angelinipharma.at/presse/2025-05-23monthly0.9https://www.angelinipharma.at/presse/news/2025-10-09monthly0.9https://www.angelinipharma.at/media/bwvpigmx/testata_area_news.jpgAngelini Pharma | Newshttps://www.angelinipharma.at/presse/news/neuer-headway-bericht-umweltkrise-hat-erhebliche-auswirkungen-auf-die-psychische-gesundheit/2023-04-04yearly0.8https://www.angelinipharma.at/media/xxgnpfkm/ap22_site_1030x302_headway_a.jpgAP22 Site 1030X302 Headway Ahttps://www.angelinipharma.at/presse/news/headway-der-neue-index-fur-psychische-gesundheit-wird-dem-europaischen-parlament-vorgestellt/2023-04-04yearly0.8https://www.angelinipharma.at/media/qvcjdjd3/headway-eu.pngHeadway EUhttps://www.angelinipharma.at/presse/news/bymyepilepside/2023-04-04yearly0.8https://www.angelinipharma.at/media/0fdgzghy/ap22_site_1030x302_epilepside.jpgAP22 Site 1030X302 Epilepsidehttps://www.angelinipharma.at/presse/news/top-employer-europe-2022/2023-04-04yearly0.8https://www.angelinipharma.at/media/epfhmate/ap_site22_1030x302_topemployer.jpgAP Site22 1030X302 Topemployerhttps://www.angelinipharma.at/presse/news/headway-2023/2023-04-04yearly0.8https://www.angelinipharma.at/media/ceyix4uh/ap_headway2023_1180x600.jpgAP Headway2023 1180X600https://www.angelinipharma.at/presse/news/angelini-unterstutzt-die-ukraine/2023-04-04yearly0.8https://www.angelinipharma.at/media/t2ykhgjq/agc_502_nils.jpgAP22 Site 1030X302 Emergency2 (1)https://www.angelinipharma.at/presse/news/angelini-pharma-und-chili-wollen-gemeinsam-das-bewusstsein-fur-psychische-gesundheit-und-neurologische-storungen-scharfen/2023-04-04yearly0.8https://www.angelinipharma.at/media/4crhvscz/ap22_italia_1030.jpgAP22 Italia 1030https://www.angelinipharma.at/presse/news/boxagrippal-mit-neuem-webauftritt/2023-04-04yearly0.8https://www.angelinipharma.at/media/zkdfqyhb/bg-new-ws.jpgBG New WS (1)https://www.angelinipharma.at/presse/news/angelini-pharma-zahlt-schritte-und-beteiligt-sich-an-50millionsteps-fur-epilepsie/2023-04-04yearly0.8https://www.angelinipharma.at/media/hq5fzamy/ap23_g_1440_50milsteps.jpgAP23 G 1440 50Milstepshttps://www.angelinipharma.at/presse/news/angelini-pharma-leistet-einen-beitrag-zur-unterstutzung-der-erdbebenopfer-in-der-turkei-und-syrien/2023-04-04yearly0.8https://www.angelinipharma.at/media/hvlev2p2/ap23_g_1030_turkey.jpgAP23 G 1030 Turkeyhttps://www.angelinipharma.at/presse/news/angelini-pharma-feiert-den-purple-day-ein-tag-der-weltweit-das-bewusstsein-fur-epilepsie-scharfen-soll/2023-04-04yearly0.8https://www.angelinipharma.at/media/ivvd12cn/ap23_g_1030_purpleday.jpgAp23 G 1030 Purpledayhttps://www.angelinipharma.at/presse/news/angelini-harmoniamentis-talks/2024-08-19yearly0.8https://www.angelinipharma.at/media/5x5nlple/hm-talks.pngHM Talkshttps://www.angelinipharma.at/presse/news/mutterschaft-und-arbeit-bei-angelini-pharma/2023-05-11yearly0.8https://www.angelinipharma.at/media/130jl0pt/shutterstock_1681663537.jpgShutterstock 1681663537https://www.angelinipharma.at/presse/news/angelini-pharma-und-jcr-pharmaceuticals-kundigen-weltweite-zusammenarbeit-bei-der-entwicklung-und-vermarktung-neuartiger-biologischer-therapien-fur-epilepsie-an/2023-05-22yearly0.8https://www.angelinipharma.at/media/q4jpwy30/ap23_g_1030_jcr.jpgAP23 G 1030 JCRhttps://www.angelinipharma.at/presse/news/thermacare-innovation-für-wohlbefinden-jetzt-auch-bei-knieschmerzen/2024-02-05yearly0.8https://www.angelinipharma.at/media/mb0ckldw/pain_infalm.jpgPain Infalmhttps://www.angelinipharma.at/presse/news/noch-mehr-schritte-fur-die-epilepsie/2024-08-19yearly0.8https://www.angelinipharma.at/media/hq5fzamy/ap23_g_1440_50milsteps.jpgAP23 G 1440 50Milstepshttps://www.angelinipharma.at/presse/news/brain-health-im-fokus-epilepsiepatient-innen-und-expert-innen-fordern-mehr-aufklarung-sensibilisierung-und-unterstutzung/2024-08-19yearly0.8https://www.angelinipharma.at/media/3cxap4ll/003-20240321-welldone-1.jpg003 20240321 Welldone 1https://www.angelinipharma.at/presse/news/angelini-pharma-startet-eine-neue-crowdsourcing-kampagne-fur-epilepsie/2024-09-02yearly0.8https://www.angelinipharma.at/media/rcqlukld/ap24_g_1030_openinginnovation.jpgAP24 G 1030 Openinginnovationhttps://www.angelinipharma.at/presse/news/am-world-brain-day-setzt-sich-angelini-pharma-mit-stolz-fur-die-gesundheit-des-gehirns-und-pravention-in-diesem-bereich-ein/2024-09-02yearly0.8https://www.angelinipharma.at/media/jnpec25v/ap24_g_1030_worldbrainday-header-news.jpgAP24 G 1030 Worldbrainday Header Newshttps://www.angelinipharma.at/presse/news/20-jahre-thermacare-tiefenwärme/2024-10-10yearly0.8https://www.angelinipharma.at/media/o3pkz15y/thermacare-20-jahre-signet-01.jpgThermacare 20 Jahre Signet 01https://www.angelinipharma.at/presse/news/angelini-pharma-steht-im-mittelpunkt-des-15-european-epilepsy-congress-in-rom/2024-09-09yearly0.8https://www.angelinipharma.at/media/lgkbfzex/ap24_g_1030_ilae_congress.jpgAP24 G 1030 ILAE Congresshttps://www.angelinipharma.at/presse/news/angelini-pharma-unterstutzt-buddy-gemeinsam-gegen-mobbing/2024-10-10yearly0.8https://www.angelinipharma.at/media/ikvdvw2w/shutterstock_1069349060.jpgShutterstock 1069349060https://www.angelinipharma.at/presse/news/angelini-pharma-uberreicht-spendenscheck-an-den-verein-buddy/2024-12-20yearly0.8https://www.angelinipharma.at/media/xxhc24v5/ethics.jpgEthicshttps://www.angelinipharma.at/presse/news/jetzt-neu-tantum-verde-protect/2025-01-23yearly0.8https://www.angelinipharma.at/media/c0vebz2g/bild1.pngBild1https://www.angelinipharma.at/presse/news/gutesiegel-fur-betriebliche-gesundheitsforderung/2025-01-21yearly0.8https://www.angelinipharma.at/media/2sbdyono/sostenibilita.jpgSostenibilitahttps://www.angelinipharma.at/presse/news/erfolgreiche-fortbildung-zu-depression-und-epilepsie-fur-medizinisches-fachpersonal/2025-05-23yearly0.8https://www.angelinipharma.at/media/1eglf1n1/bh-days-banner.pngBH Days Bannerhttps://www.angelinipharma.at/presse/presseaussendungen/2025-10-08monthly0.9https://www.angelinipharma.at/media/vqoncgl4/cover_press_relase.jpgCover Press Relasehttps://www.angelinipharma.at/presse/presseaussendungen/welttag-fur-psychische-gesundheit-der-neue-headway-bericht-hebt-die-bestimmenden-umweltfaktoren-psychischer-gesundheit-hervor/2023-04-04yearly0.8https://www.angelinipharma.at/media/1r0nnr0e/ap22_site_1030x302_headway_post.jpgAP22 Site 1030X302 Headway POSThttps://www.angelinipharma.at/presse/presseaussendungen/cenobamat-erhalt-eu-zulassung/2023-09-04yearly0.8https://www.angelinipharma.at/media/beilbq4w/ap_ontozry_1440x500.jpgAP Ontozry 1440X500https://www.angelinipharma.at/presse/presseaussendungen/ovid-therapeutics-und-angelini-pharma-schliessen-eine-exklusive-lizenzvereinbarung-zur-entwicklung-herstellung-und-vermarktung-von-ov101-fur-die-behandlung-des-angelman-syndroms/2023-04-04yearly0.8https://www.angelinipharma.at/media/2fipjkde/rare_deseas_header.jpgBanner Hp Comunicatostampa (1)https://www.angelinipharma.at/presse/presseaussendungen/headway-2023-mental-health-index/2023-04-04yearly0.8https://www.angelinipharma.at/media/mpmifasw/ap_headway2023_1180x600.jpgdiversityhttps://www.angelinipharma.at/presse/presseaussendungen/angelini-pharma-ernennt-rafal-kaminski-zum-neuen-chief-scientific-officer/2023-04-04yearly0.8https://www.angelinipharma.at/media/i0hgguap/ap_site22_1030x302_kaminski.jpgAP Site22 1030X302 Kaminskihttps://www.angelinipharma.at/presse/presseaussendungen/neue-therapieoptionen-bei-epilepsie-hohere-chancen-auf-anfallsfreiheit/2023-04-04yearly0.8https://www.angelinipharma.at/media/g24nyip2/screenshot-2022-04-29-121158.pngScreenshot 2022 04 29 121158https://www.angelinipharma.at/presse/presseaussendungen/the-european-house-ambrosetti-und-angelini-pharma-stellen-den-headway-epilepsy-report-vor/2023-04-04yearly0.8https://www.angelinipharma.at/media/2z3h0wba/screenshot-2022-07-28-122248.pngScreenshot 2022 07 28 122248https://www.angelinipharma.at/presse/presseaussendungen/angelini-industries-ernennt-jacopo-andreose-zum-neuen-ceo-von-angelini-pharma/2023-04-04yearly0.8https://www.angelinipharma.at/media/xgmfeyve/ap_ceo_andreose.pngAp Ceo Andreosehttps://www.angelinipharma.at/presse/presseaussendungen/europäische-kommission-genehmigt-die-erweiterung-der-bestehenden-indikation-von-xydalba-bei-absssi-auf-kinder/2023-04-04yearly0.8https://www.angelinipharma.at/media/5exdieun/ap22_1030_xydalba2.jpgAP22 1030 Xydalba2https://www.angelinipharma.at/presse/presseaussendungen/angelini-pharma-und-jcr-pharmaceuticals-kundigen-weltweite-zusammenarbeit-bei-der-entwicklung-und-vermarktung-neuartiger-biologischer-therapien-fur-epilepsie-an/2023-05-22yearly0.8https://www.angelinipharma.at/media/q4jpwy30/ap23_g_1030_jcr.jpgAP23 G 1030 JCRhttps://www.angelinipharma.at/presse/presseaussendungen/epilepsie-expert-innen-und-betroffene-fordern-mehr-aufklarung-sensibilisierung-und-unterstutzung/2024-08-19yearly0.8https://www.angelinipharma.at/media/3cxap4ll/003-20240321-welldone-1.jpg003 20240321 Welldone 1https://www.angelinipharma.at/presse/presseaussendungen/angelini-pharma-und-sk-biopharmaceuticals-versorgen-weltweit-mehr-als-100-000-patient-innen-mit-cenobamat/2024-08-19yearly0.8https://www.angelinipharma.at/media/nqtmwkjp/ap24_g_1030_ontozrytreatment.jpgAP24 G 1030 Ontozrytreatmenthttps://www.angelinipharma.at/presse/presseaussendungen/mental-fit-mach-mit-eine-initiative-von-angelini-pharma-osterreich/2024-08-19yearly0.8https://www.angelinipharma.at/media/iytnjvhf/selbsttest-mentale-fitness.jpgSelbsttest Mentale Fitnesshttps://www.angelinipharma.at/presse/presseaussendungen/angelini-pharma-startet-neues-crowdsourcing-projekt-zur-finanzierung-innovativer-losungen-fur-epilepsie/2024-09-02yearly0.8https://www.angelinipharma.at/media/rcqlukld/ap24_g_1030_openinginnovation.jpgAP24 G 1030 Openinginnovationhttps://www.angelinipharma.at/presse/presseaussendungen/angelini-pharma-schliesst-mit-cureverse-einen-exklusiven-optionsvertrag-zur-genehmigung-globaler-entwicklungs-und-vermarktungsrechte-fur-einen-neuen-und-innovativen-brain-health-wirkstoff-im-klinischen-stadium-ab/2024-10-25yearly0.8https://www.angelinipharma.at/media/e3npdere/ap24_g_1030_cs_accordo.jpgAP24 G 1030 Cs Accordohttps://www.angelinipharma.at/media/o0nlv4m0/pressemappe.zip2024-05-16yearly0.8https://www.angelinipharma.at/media/3cxap4ll/003-20240321-welldone-1.jpg003 20240321 Welldone 1https://www.angelinipharma.at/therapiegebiete/focus-on/2023-04-04monthly0.9https://www.angelinipharma.at/media/pl3fkk01/focus_on.jpgFocus Onhttps://www.angelinipharma.at/therapiegebiete/scientific-updates/2023-04-04monthly0.9https://www.angelinipharma.at/media/331aqtze/scientific-update.jpgScientific Updatehttps://www.angelinipharma.at/therapiegebiete/brain-health/2025-10-27yearly0.8https://www.angelinipharma.at/media/i3zj0zhq/brainhealth_1030.jpgBrainhealth 1030https://www.angelinipharma.at/therapiegebiete/brain-health/psychische-gesundheit/2024-08-26yearly0.8https://www.angelinipharma.at/media/lifpmykv/focusmentalhealth.jpgFocusmentalhealthhttps://www.angelinipharma.at/therapiegebiete/brain-health/zentralnervensystem/2024-08-19yearly0.8https://www.angelinipharma.at/media/yv2j0iej/epilepsy_1030.jpgEpilepsy 1030https://www.angelinipharma.at/therapiegebiete/consumer-health/2025-10-27yearly0.8https://www.angelinipharma.at/media/2fipjkde/rare_deseas_header.jpgBanner Hp Comunicatostampa (1)https://www.angelinipharma.at/therapiegebiete/consumer-health/erkaltung/2024-08-19yearly0.8https://www.angelinipharma.at/media/n3tg1vjq/customer_health.jpgCustomer Healthhttps://www.angelinipharma.at/therapiegebiete/consumer-health/schmerzen/2025-10-27yearly0.8https://www.angelinipharma.at/media/mb0ckldw/pain_infalm.jpgPain Infalmhttps://www.angelinipharma.at/therapiegebiete/consumer-health/gynakologie/2025-10-27yearly0.8https://www.angelinipharma.at/media/qrslgphi/adobestock_172050864.jpegAdobestock 172050864https://www.angelinipharma.at/therapiegebiete/consumer-health/selbstmedikation/2025-10-27yearly0.8https://www.angelinipharma.at/media/g3tbzxhm/rarediseases_1030.jpgRarediseases 1030https://www.angelinipharma.at/therapiegebiete/infektiologie/2024-09-02yearly0.8https://www.angelinipharma.at/media/pnlh0ms0/adobestock_298001238.jpegAdobestock 298001238https://www.angelinipharma.at/therapiegebiete/onkologie/2024-09-02yearly0.8https://www.angelinipharma.at/media/uzupiumv/adobestock_183200379.jpegAdobestock 183200379https://www.angelinipharma.at/produkte/2026-03-09never0.5https://www.angelinipharma.at/media/1lfdmfzr/prodotti-s.jpgProdotti Shttps://www.angelinipharma.at/produkte/acutil/2023-04-04yearly0.8https://www.angelinipharma.at/produkte/boxagrippal/2023-04-04yearly0.8https://www.angelinipharma.at/produkte/boxaimmun/2023-04-04yearly0.8https://www.angelinipharma.at/produkte/heumann-bronchialtee/2026-03-09yearly0.8https://www.angelinipharma.at/produkte/heumann-blasen-und-nierentee/2023-04-04yearly0.8https://www.angelinipharma.at/produkte/tantum-grip/2023-12-06yearly0.8https://www.angelinipharma.at/produkte/tantum-verde/2023-12-06yearly0.8https://www.angelinipharma.at/produkte/thermacare/2023-04-04yearly0.8https://www.angelinipharma.at/produkte/rezeptpflichtige-arzneispezialitaten/2025-04-07yearly0.8https://www.angelinipharma.at/forschung-und-entwicklung/wissenschaft-und-innovation/2025-10-08yearly0.8https://www.angelinipharma.at/media/zminzlm3/pipeline_1030.jpgPipeline 1030https://www.angelinipharma.at/forschung-und-entwicklung/kooperationen-in-der-forschung/2025-10-09yearly0.8https://www.angelinipharma.at/media/1bod01bu/partner_2.jpgPartner 2https://www.angelinipharma.at/unsere-verantwortung/ethik/2026-01-19yearly0.8https://www.angelinipharma.at/media/2hphkifr/ethics_1030.jpgEthics 1030https://www.angelinipharma.at/unsere-verantwortung/qualitat-und-ehs/2025-10-08yearly0.8https://www.angelinipharma.at/media/inacu5rv/transparency_1030.jpgTransparency 1030https://www.angelinipharma.at/unsere-verantwortung/transparenz/2025-11-06yearly0.8https://www.angelinipharma.at/media/3e0krnfb/focus-s.jpgdiversityhttps://www.angelinipharma.at/unsere-verantwortung/transparenz/hungary/2025-11-06yearly0.8https://www.angelinipharma.at/unsere-verantwortung/transparenz/slovak-republic/2023-04-04yearly0.8https://www.angelinipharma.at/unsere-verantwortung/transparenz/other-countries/2023-04-04yearly0.8https://www.angelinipharma.at/unsere-verantwortung/transparenz/patient-innenorganisationen/2025-06-24yearly0.8https://www.angelinipharma.at/media/vkvj2xhk/sustainability_1030.jpgSustainability 1030https://www.angelinipharma.at/unsere-verantwortung/produktsicherheit/2024-09-02yearly0.8https://www.angelinipharma.at/media/5mgj4yu0/testata_1024x300.jpgTestata 1024X300 (1)https://www.angelinipharma.at/uber-uns/uber-uns/2025-10-30yearly0.8https://www.angelinipharma.at/media/qkyljtvr/whoweare_1030.jpgWhoweare 1030https://www.angelinipharma.at/uber-uns/vision-mission-werte/2025-10-27yearly0.8https://www.angelinipharma.at/media/3fgmbkrc/covermission-vision.jpgDonna di spalle con le braccia aperte di fronte a un lagohttps://www.angelinipharma.at/uber-uns/wichtige-fakten-und-ereignisse/2025-11-06yearly0.8https://www.angelinipharma.at/media/4hppt051/history.jpgBoccette e scatole antiche di medicinalihttps://www.angelinipharma.at/uber-uns/people/2025-10-29monthly0.9https://www.angelinipharma.at/media/whcfl3vm/people_1024x300.jpgPeople 1024X300https://www.angelinipharma.at/uber-uns/people/alberto-bellenghi/2023-09-18yearly0.8https://www.angelinipharma.at/media/hwufwu5y/dsc_8109.jpgDSC 8109https://www.angelinipharma.at/uber-uns/people/michaela-holzer/2024-07-01yearly0.8https://www.angelinipharma.at/media/fjmfkzmw/regulatory-quality-head-at-michaela-holzer.jpgRegulatory & Quality Head AT Michaela Holzerhttps://www.angelinipharma.at/uber-uns/people/mirjana-mayerhofer/2024-07-01yearly0.8https://www.angelinipharma.at/media/kb0anzqr/country-manager-athu-mirjana-mayerhofer.jpgCountry Manager ATHU Mirjana Mayerhoferhttps://www.angelinipharma.at/uber-uns/people/gabriele-winsauer/2024-08-14yearly0.8https://www.angelinipharma.at/media/fztjw1w2/medical-head-athu-gabriele-winsauer.jpgMedical Head ATHU Gabriele Winsauerhttps://www.angelinipharma.at/uber-uns/people/michal-sekera/2024-08-14yearly0.8https://www.angelinipharma.at/media/tsgbrqgl/dsc_8115.jpgDSC 8115https://www.angelinipharma.at/uber-uns/people/christian-behrend/2025-01-21yearly0.8https://www.angelinipharma.at/media/r3hhui3d/christian-behrend.jpgChristian Behrendhttps://www.angelinipharma.at/uber-uns/standorte/2025-10-27monthly0.9https://www.angelinipharma.at/media/jnfl2ufp/sites.jpgSiteshttps://www.angelinipharma.at/uber-uns/standorte/ancona/2024-08-19yearly0.8https://www.angelinipharma.at/media/g5obpqqr/veduta-aerea-aerial-view.webpVeduta Aerea Aerial Viewhttps://www.angelinipharma.at/uber-uns/standorte/albany-thermacare/2024-08-19yearly0.8https://www.angelinipharma.at/media/2qjpe5ur/thermacare2.webpThermacare2https://www.angelinipharma.at/uber-uns/standorte/aprilia/2024-08-19yearly0.8https://www.angelinipharma.at/media/yqfcqorb/testata_aprilia.webpTestata Apriliahttps://www.angelinipharma.at/uber-uns/standorte/barcelona-sant-quirze-del-valles/2024-08-19yearly0.8https://www.angelinipharma.at/media/ut5kx1er/stabilimento-barcellona.jpgStabilimento Barcellona (1)https://www.angelinipharma.at/nutzungsbedingungen/2025-11-10never0.5https://www.angelinipharma.at/datenschutz/2025-11-10never0.5https://www.angelinipharma.at/datenschutz/datenschutz-bewerber-innen/2025-11-10yearly0.8https://www.angelinipharma.at/datenschutz/datenschutz-veranstaltungen/2025-11-10yearly0.8https://www.angelinipharma.at/datenschutz/datenschutz-vertrags-und-geschaftspartner-innen/2025-11-10yearly0.8https://www.angelinipharma.at/datenschutz/datenschutz-website/2025-11-10yearly0.8https://www.angelinipharma.at/datenschutz/datenschutz-medizinische-anfragen-und-pharmakovigilanz/2025-11-10yearly0.8https://www.angelinipharma.at/cookie-policy/2025-11-10never0.5https://www.angelinipharma.at/kontakt/2025-11-10never0.5https://www.angelinipharma.at/sitemap/2023-04-04never0.5https://www.angelinipharma.at/agb/2026-02-05never0.5https://www.angelinipharma.at/impressum/2025-11-10never0.5https://www.angelinipharma.at/jobs-und-karriere/2025-02-23monthly0.9https://www.angelinipharma.at/jobs-und-karriere/arbeiten-bei-angelini-pharma/2025-04-29yearly0.8https://www.angelinipharma.at/media/0xfh4gry/ap22_1030x302_bic22.jpgAngelini Pharma Best Employers For Woman